Prospective, multicentric, open label, clinical study to evaluate efficacy and safety of R-TPR-020 in patients undergoing treatment for infertility.
Phase of Trial: Phase III
Latest Information Update: 11 May 2018
At a glance
- Drugs Choriogonadotropin alfa (Primary)
- Indications Female infertility
- Focus Therapeutic Use
- Sponsors Reliance Life Sciences
- 07 Jul 2010 Status changed from recruiting to completed as reported by Clinical Trials Registry - India.
- 13 Feb 2010 New trial record